Bilix Co.,Ltd.

2 clinical trials · Sponsor

Record	Firm	Date
A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE) (NCT07164833)	Bilix Co.,Ltd.	2025-08-26
A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants (NCT06097702)	Bilix Co.,Ltd.	2023-11-17

Every clearance here is in the API, with alerts when new ones post.